Virtual monitoring for stable chronic hepatitis B patients does not reduce adherence to medications: A randomised controlled study.

Rajneesh KumarMei-Ling YeeGeorge Bb GohPei-Yuh ChiaHwei-Ling LeeX XinPek Se TeoVictoria Sm EkstromJin Yt TanMark Cc CheahYu T WangJason Pe ChangChee Kiat TanHiang Keat TanThinesh L KrishnamoorthyWan-Cheng Chow

Published in: Journal of telemedicine and telecare (2021)

VMC is a viable and safe clinical model for monitoring stable CHB patients on NA therapy without compromising patients' adherence to medications and is preferred by patients.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
type diabetes
prognostic factors
clinical trial
metabolic syndrome
stem cells
mesenchymal stem cells
hepatitis b virus
insulin resistance
smoking cessation
replacement therapy